The global spinal fusion market size is estimated at US$ 9,945.5 million in 2023. Adoption of spinal fusion is projected to climb at a 5.4% CAGR between 2023 and 2033, surpassing US$ 16,771.8 million by 2033.
Key Highlights
| Attributes | Details |
|---|---|
| Spinal Fusion Market Size (2023) | US$ 9,945.5 million |
| Spinal Fusion Market Projected Size (2033) | US$ 16,771.8 million |
| Forecasted Value CAGR (2023 to 2033) | 5.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising Incidence of Spinal Illnesses Sparks Market Growth: The growing incidence of spinal illnesses is driving the growth of the spinal fusion market. Based on the data provided by the CDC, spinal abnormalities impacted about 34.0% of young adults and 62.0% of the senior population in 2019. Trauma falls, crashes, or accidents while driving are prominent reasons for spinal fusion injuries. Degenerative disc degeneration, spinal stenosis, and herniated discs are becoming increasingly common. Many people's spinal discs deteriorate over time. Around 30% of persons exhibit signs of disc degeneration at one or more levels by the age of 35. Over 90% of persons are going to have some degree of disc degeneration by the age of 60. This surge in spinal disorders necessitates a corresponding rise in surgical interventions, including spinal fusion.
Aging Population Faces Growing Epidemic of Spinal Disorders: As per the estimates of the World Health Organization in May 2021, by 2030, one out of every six persons on the earth is going to be 60 or older. Individuals aged 60 and older are predicted to increase from 1 billion in 2020 to 1.4 billion by 2050. Declining birth rates and a longer lifespan are leading people to age fast all over the world, particularly in the United States, Japan, and Western Europe. Spinal diseases, such as spinal stenosis, are the main cause of disability in men and women over the age of 45. The aging population, notably those with comorbidities and/or reduced immunity, is at a significant risk for spinal abnormalities. This demographic trend directly contributes to the growing demand for spinal fusion procedures.
Healthcare Investments Propel Growth of Spinal Fusion Market: The spinal fusion devices market is getting a boost from countries investing more in their healthcare systems. Places like India are building more hospitals, which means more people can get good healthcare. Improvements in healthcare infrastructure have expanded access to advanced surgical procedures like spinal fusion. This has led to a broader patient base seeking these treatments. When a country puts more money into making healthcare better, it helps the spinal fusion market grow. For example, in India, the government is making efforts to build more hospitals. This means that more people can get good healthcare services. And with better hospitals, more people might choose to have treatments like spinal fusion. So, the investment in healthcare infrastructure is indeed helping the spinal fusion market to expand.
Lifestyle Factors Fuel Demand for Spinal Surgeries: In the United States, around 1 million instrumented spinal surgeries are conducted each year. Lifestyle factors, including sedentary behavior and obesity, have contributed to an increase in chronic back pain cases. In the past few years, spinal surgery has achieved incredible advancements. Several individuals have benefited from minimally invasive procedures for spine surgery. These make surgery more secure, with a lesser loss of blood, minimal discomfort afterward, and faster recoveries. However, the future appears to be much better. New and better surgical approaches, as well as technological and biological developments, are on the verge of becoming reality. Ongoing advances in spinal fusion surgical procedures, such as artificial disc replacement surgery and endoscopic spine surgery, have made significant improvements in patient outcomes.
Rising Demand for Lumbar Spinal Fusion Devices: Lumbar fusion is a difficult procedure that involves the placement of screws within the vertebrae to be joined. Fusion surgery is one of the most frequent surgical treatments for the spine, based on the research named Establishment of a Novel Method for Spinal Discectomy Surgery in Elderly Rats in an In Vivo Spinal Fusion Model, released in December 2021. In the United States, around 400,000 spinal fusions are carried out each year, with a projected cost of US$ 32 billion. Therefore, increased usage of lumbar fusion surgery is expected to increase demand for lumber spinal fusion devices, driving spinal fusion market growth.
Between 2017 and 2022, the spinal fusion market share reached from US$ 7,567.4 million to US$ 9,494.8 million, registering a 4.6% CAGR. In recent years, the number of spine fusion procedures has progressively grown. Weight, food, smoking, and other lifestyle variables can all contribute to spinal abnormalities. Toxins in cigarette smoke are thought to be responsible for the early development of degenerative spinal abnormalities. For example, according to data provided by the National Health Portal of India in February 2020, 250,000-500,000 persons worldwide suffer from spinal cord injury each year. More than half of these occurrences are the result of avoidable causes such as car accidents, falls, and assaults. Premature fatalities are anywhere from two to five times more likely in those with spinal cord injuries than in people without.
| Spinal Fusion Market Size (2017) | US$ 7,567.4 million |
|---|---|
| Spinal Fusion Market Size (2022) | US$ 9,494.8 million |
| Historical Value CAGR (2017 to 2022) | 4.6% |
Looking ahead to 2023, the expanding effect of minimally invasive operations is expected to boost the growth possibilities of the spinal fusion devices market. The increasing investment of several nations in improving healthcare infrastructure has the potential to be a beneficial driver for the expansion of the spinal fusion market. Recent advancements in minimally invasive techniques and the growing preference for motion-preserving procedures are notable cervical spinal fusion market trends.
The spinal fusion market size is projected to reach from US$ 9,945.5 million in 2023 to US$ 16,771.8 million by 2033, exhibiting a 5.4% CAGR. The expanding senior population worldwide could significantly boost the spinal fusion market opportunity. As a result, all of these elements are going to stimulate significant development. The market is likely to experience significant growth in research and development activity. The spinal fusion devices market players are expected to invest substantially in research and development to produce novel compositions and improvements to the devices. These features are projected to make the product more accessible and beneficial to the consumer.
The spinal arthrodesis device market is extremely competitive, with prominent competitors regularly launching fresh and upgraded products to preserve their market dominance. Manufacturers are developing advanced devices specifically for spinal fusion procedures. For example, Spine Wave announced the instant availability of both the Defender Anterior Cervical Plate and the Stronghold C 3D Titanium Interbody Device with TiCell 3D revolutionary interface technology in December 2021. The Defender Anterior Cervical Plate is a titanium plate and screw system used for anterior cervical fusion surgeries.
Principal Consultant
Emergence of Minimally Invasive Surgery in Spinal Fusion: The advancement of minimally invasive fusion surgical techniques has brought about a significant transformation in how spinal fusion procedures are performed. Unlike traditional open surgeries, minimally invasive approaches involve smaller incisions and the use of specialized instruments and cameras to perform the procedure. This innovation has proven to be a game-changer for both patients and healthcare providers. Patients undergoing minimally invasive spinal fusion experience several notable advantages. They tend to have shorter hospital stays compared to those undergoing traditional open surgeries. Additionally, the smaller incisions and less tissue disruption lead to less discomfort during the recovery period.
Spinal Fusion Techniques Forge New Frontiers beyond Tradition: Spinal fusion techniques, once mainly used for typical spinal problems, are now finding new applications. They are being employed for a wider range of conditions beyond the usual spinal disorders. This expansion encompasses areas like trauma, where injuries may require stabilizing the spine. Moreover, it is being used in tumor resection, helping in the surgical removal of spinal tumors. This diversification of applications is broadening the spinal fusion market opportunity. This trend reflects the versatility and effectiveness of spinal fusion techniques, positioning them as a valuable tool in a wider array of medical scenarios.
As per our spinal fusion market data, in 2022, North America solidified its leadership in the global spinal fusion market, capturing a 33.0% share. This was attributed to its robust healthcare infrastructure and early embrace of advanced medical technologies. Europe closely followed with a 28.2% share, driven by stringent regulatory frameworks and a well-established healthcare system.
| Country | 2022 Value Share in Global Market |
|---|---|
| United States | 29.3% |
| Germany | 4.7% |
| Japan | 14.2% |
The United States is predicted to have the maximum market share in North America. The USA spinal fusion market has taken control of the global market as well. This dominance is projected to continue in the decades to come as the number of individuals struggling with lower back pain and other spine-related ailments ascends each year. Orthopedic treatment is one of the most common, costly, and rapidly rising segments of healthcare in the United States. In 2021, more than one-third of the United States population got orthopedic treatment, resulting in the most costly expense category for employer-based insurance enrollees and second in size for Medicare.
In the United States, the yearly prevalence of spinal cord injury (SCI) is about 54 incidences per million persons, resulting in around 18,000 fresh SCI cases every year as per the National Spinal Cord Injury Statistical Center report circulated in in 2020. The projected number of people suffering from SCI in the United States is around 302,000, with a range of 255,000 to 383,000. As a result, the rising prevalence of spinal cord injury is expected to fuel demand for spinal fusion devices, supporting market growth.
Several market participants additionally participate in strategic initiative execution, which contributes to market growth. Stryker, for example, plans to launch a novel device for spinal fusion surgery in October 2022. It is constructed of perforated and rigid structures. It incorporates the company's unique Tritanium In-Growth technology. In addition, Jennifer M Bauer (Seattle Children's Hospital, Seattle, the United States) laid out a recent research study at the Scoliosis Research Society's (SRS) 57th annual meeting in October 2022, which demonstrated that the use of a preoperative carbohydrate drink for pediatric spinal fusion patients could accelerate time recuperation of intestinal motility.
In 2022, an estimated 10,360 spinal cord injuries have been documented in Germany. According to the OECD study The Heavy Burden of Obesity, 2019, one out of four adult citizens in Germany is obese. As a result of this, it cuts Germans' lifespan by 2.6 years on average owing to obesity. These figures are anticipated to rise considerably as lifestyles and food consumption patterns evolve. Overweight is projected to cause a rise in degenerative spinal diseases and an upsurge in spinal difficulties in obese populations. In addition, as the senior population grows, the number of persons experiencing lower back pain and other degenerative spinal disorders is also expected to rise throughout the projection period.
Key players continue to vie for prominence in the spinal fusion device market share by developing novel products. In June 2022, NGMedical GmbH, a company that produces medical devices wholly centered on developing novel spinal technologies, revealed the release of its new ART® Fixation System. It was designed with the intention of giving the surgeon a fixation method that could allow him or her to conduct dorsal spinal fusion stabilizations easily, swiftly, and efficiently. This is an intriguing improvement on NGMedical's growing product line.
Japan’s spinal fusion device market size has demonstrated steady expansion. With a population of over 127 million people, Japan is a significant market for spinal implants. The senior population, which is prone to suffer spinal injuries, is anticipated to have an essential part in the market's continued development. According to the JTC article released in September 2022, Japan's population over 75 years old accounts for more than 15% of the whole population, while those over 65 years old account for 29.1% of the overall population.
The incidence of sports injuries resulting in spinal injuries or fractures in the population is also likely to boost market growth. According to a JNS report published in August 2021, the rate of spinal cord damage in sports-related serious spinal injuries in Japan remained at 13% for cycling injuries, while it was 41% and 49% for contract sports and aquatic sports injuries, respectively. As a result, the increased prevalence of sports injuries necessitating spinal surgical treatments is likely to fuel market growth through 2033. In January 2022, Japan conducted a world-first spinal cord cell therapy experiment in search of a treatment for spinal injury-related paralysis.
| Country | Value CAGR between 2023 and 2033 |
|---|---|
| United Kingdom | 3.3% |
| India | 7.4% |
| China | 12.3% |
There are an anticipated 50,000 persons in the United Kingdom who have a spinal cord injury, and about 2,500 people get injured annually. The pandemic has changed the dynamics of the healthcare value chain after three years in the United Kingdom. The years 2020 to 2022 were difficult for payers and providers. During this period, their commitment to uninterrupted service innovation and expansion was evident. A longitudinal study was undertaken involving patients from eight collaborating spinal facilities across the United Kingdom, according to a research paper published in December 2021 in the BJO open-access journal, and around 65% of the patients had degenerative spine illnesses treated with spinal fusion during this period. The outlook over the upcoming few years is promising. With a projected steady growth rate, the spinal fusion device market size in the United Kingdom is anticipated to reach new heights in the coming years.
Spinal cord injuries occur at a rate of 15 per million people in India. The spinal fusion market is likely to rise rapidly in the next years as a result. Demand for spinal surgical instruments and the return of surgical alternatives is rising as well. Stryker, for example, forecasted an increase in total revenue from the spine space in its annual report 2021. In FY2021, the spine segment earned US$ 1,167 million in revenue, up from US$ 1,047 million in FY2020. As a result, the market is likely to grow in the next years.
In recent years, there has been a greater effort to concentrate on strengthening India's healthcare infrastructure. In addition to constructing new healthcare facilities and improving existing ones, infrastructure for training and human capital development has been vastly improved. Medical tourism is also a significant driving force in the spinal fusion market. In comparison to other nations, the pricing of spinal fusion devices and spinal procedures in India is affordable. As a result, patients from all over the world are flocking to India for therapy and spinal surgery.
The rising prevalence of obesity, diabetes, degenerative spinal disorders, and the rising acceptance rate of minimally invasive fusion operations are expected to be primary drivers of market expansion throughout the forecast period. According to the research named "Prevalence, Incidence, and External Causes of Traumatic Spinal Cord Injury in China: A Nationally Representative Cross-Sectional Survey," published in January 2022, it is projected that about 759,302 prevalent individuals suffering from severe spinal cord injuries and 66,374 fresh traumatic spinal cord damage cases are identified in China each year. As a result, such incidents are expected to drive demand for spinal fusion devices in China, driving market growth throughout the forecast period.
Spinal fusion is among the most commonly recommended operations for back disorders, and rising spinal fusion surgery volumes in China are likely to boost spinal fusion equipment market expansion. Moreover, the spinal fusion instrumentation market is witnessing an upsurge in China. This growth is spurred by innovations in surgical techniques and the development of specialized instrumentation tailored to meet the evolving demands of modern spinal procedures. In June 2022, a long-standing strategic relationship between Beijing Fule and Invibio Biomaterial Solutions contributed to the invention of an entirely novel interbody fusion device, including the first high-performance medical fusion cage product in China based on PEEK-OPTIMATM HA Enhanced polymers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product type, the market is segmented into interbody cages, pedicle screws and rods, and spinal fusion plates. The pedicle screws and rods segment dominated the global market in 2022, accounting for a 52.0% share. In a similar vein, when considering the product type, the spiral fusion market is divided into posterolateral fusion and interbody fusion. Notably, the interbody fusion segment took the lead, commanding an impressive 55.4% market share in 2022.
| Segment | 2022 Value Share in Global Market |
|---|---|
| Pedicel Screws and Rods | 52.0% |
| Interbody Fusion | 55.4% |
The dominance of the pedicle screws and rods segment in the spinal fusion market since these components form the foundation of many spinal fusion procedures. Hence, these provide crucial stability and support to the spine during the healing process. Pedicle screws anchor firmly into the vertebral pedicles and offer a robust foundation for the fusion process. Technology has also improved these components. They can now be customized to fit each patient's unique anatomy. This makes the fusion procedure more precise and effective. Studies consistently show that pedicle screw and rod systems are safe and effective. This builds trust among both surgeons and patients, reinforcing their popularity.
Given its ability to address multiple spinal disorders effectively, interbody fusion has emerged as the cornerstone of the spinal fusion market. Unlike some other methods, interbody fusion lets doctors reach the space between the discs in the spine. This makes it easier to take out damaged discs and join the nearby bones together. Additionally, the use of interbody implants made from materials like titanium or polyetheretherketone (PEEK) provides a stable scaffold for bone growth. Moreover, interbody fusion demonstrates favorable clinical outcomes and relatively low complication rates. This instills confidence among both surgeons and patients. The technique's proven track record in treating conditions like degenerative disc disease, spondylolisthesis, and spinal stenosis further solidifies its dominance.
The global spinal fusion market is extremely fragmented, with multiple players vying for market share. To meet customer demand and expand their client base, these companies are implementing various methods such as collaborations, partnerships, mergers and acquisitions, and new product releases.
Recent Developments in the Spinal Fusion Market
The global spinal fusion market is presently valued at US$ 9,945.5 million as of 2023.
The global spinal fusion market size is projected to surpass US$ 16,771.8 million by 2033, recording a 5.4% CAGR.
The global spinal fusion market holds more than 73% of the global spinal implants & devices market.
The latest technology for spinal fusion involves advanced implants, minimally invasive techniques, and biologics to enhance fusion success rates.
Countries with aging populations like the United States, Japan, and Germany are poised to drive demand for spinal fusion due to increasing spinal issues.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Interbody Cages
5.3.2. Pedicle Screws and Rods
5.3.3. Plates
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Procedure, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure, 2023 to 2033
6.3.1. Posterolateral Fusion
6.3.2. Interbody Fusion
6.3.2.1. Anterior Lumbar Interbody Fusion (ALIF)
6.3.2.2. Extreme Lateral Interbody Fusion (XLIF)
6.3.2.3. Posterior Lumbar Interbody Fusion (PLIF)
6.3.2.4. Transformational Lumbar Interbody Fusion (TLIF)
6.3.2.5. Others
6.4. Y-o-Y Growth Trend Analysis By Procedure, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Procedure, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Ambulatory Surgical Centers
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Procedure
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Procedure
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Procedure
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Procedure
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Procedure
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Procedure
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Procedure
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Procedure
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Procedure
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Procedure
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Procedure
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Procedure
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Procedure
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Procedure
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Procedure
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Procedure
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Procedure
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Procedure
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Procedure
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Procedure
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Procedure
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Procedure
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Procedure
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Procedure
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Procedure
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Procedure
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Procedure
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Procedure
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Procedure
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Procedure
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Procedure
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Procedure
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Procedure
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Procedure
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Procedure
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product
16.22.2.2. By Procedure
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product
16.23.2.2. By Procedure
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Procedure
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Zimmer Biomet Holdings, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Stryker Corporation, Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Exactech, Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Medtronic Plc
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Johnson & Johnson Services, Inc (Depuy Synthes)
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Wenzel Spine, Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Centinel Spine, Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Spineart Geneva SA
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. K2M, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. MicroPort Scientific Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Integra Lifesciences Holdings Corp
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Orthofix Holdings, Inc.
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Shandong Weigao Group Medical Polymer Company Limited
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Bonovo Orthopedics, Inc.
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.15. Suzhou Gemmed Medical Instrument Co. Ltd
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.16. NuVasive, Inc.
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments
18.1.16.4. Sales Footprint
18.1.16.5. Strategy Overview
18.1.16.5.1. Marketing Strategy
18.1.17. B. Braun Melsungen AG
18.1.17.1. Overview
18.1.17.2. Product Portfolio
18.1.17.3. Profitability by Market Segments
18.1.17.4. Sales Footprint
18.1.17.5. Strategy Overview
18.1.17.5.1. Marketing Strategy
18.1.18. Globus Medical Inc.
18.1.18.1. Overview
18.1.18.2. Product Portfolio
18.1.18.3. Profitability by Market Segments
18.1.18.4. Sales Footprint
18.1.18.5. Strategy Overview
18.1.18.5.1. Marketing Strategy
18.1.19. RTI Surgical, Inc.
18.1.19.1. Overview
18.1.19.2. Product Portfolio
18.1.19.3. Profitability by Market Segments
18.1.19.4. Sales Footprint
18.1.19.5. Strategy Overview
18.1.19.5.1. Marketing Strategy
18.1.20. Expanding Orthopedics Inc.
18.1.20.1. Overview
18.1.20.2. Product Portfolio
18.1.20.3. Profitability by Market Segments
18.1.20.4. Sales Footprint
18.1.20.5. Strategy Overview
18.1.20.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Spinal Fusion Market
